Cancers, Guidance
13 results
Trastuzumab: informing intrathecal risk assessment
18 April 2026Trastuzumab products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
Hydrocortisone: informing intrathecal risk assessment
18 April 2026Hydrocortisone products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
Thiotepa: informing intrathecal risk assessment
18 April 2026Thiotepa products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
Topotecan: informing intrathecal risk assessment
18 April 2026Topotecan products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
Rituximab: informing intrathecal risk assessment
18 April 2026Rituximab products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
Etoposide: informing intrathecal risk assessment
18 April 2026Etoposide products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
Cytarabine: informing intrathecal risk assessment
18 April 2026Cytarabine products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
Hydrocortisone acetate: informing intrathecal risk assessment
18 April 2026Hydrocortisone acetate products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
Understanding risks with intrathecal administration
17 June 2025The intrathecal route is a high-risk route of administration. Incorrect administration of medicines unsafe for this route can result in patient death.
Preventing harm from incorrect vinca alkaloid administration
13 June 2025Vinca alkaloids can cause paralysis and death if given by the wrong route. Understand how to reduce the risk to patients.